Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre® net sales of $71.3 million (+95% vs Q4 2024)
Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update
Seeking Alpha / 11 hours ago 2 Views
Seeking Alpha / 11 hours ago 2 Views
Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre® net sales of $71.3 million (+95% vs Q4 2024)
Comments